Spis treści:
1. REPORT
2. INFORMATION ABOUT THE ENTITY
3. SIGNATURE OF PERSONS REPRESENTING THE COMPANY

Spis załączników:
  1. 2024 Supervisory Board Report.pdf2024 Supervisory Board Report

POLISH FINANCIAL SUPERVISION AUTHORITY

UNI - EN REPORT No 19 / 2025
Date of issue: 2025-04-10
Short name of the issuer
KRKA
Subject
2024 Supervisory Board Report of Krka, d. d., Novo mesto
Official market - legal basis
art. 17. 1 MAR.
Unofficial market - legal basis
Contents of the report:
Based on the provisions of the Rules of the Ljubljana Stock Exchange, d. d., Ljubljana and Article 134 of the Market in Financial Instruments Act, Krka, d. d., Novo mesto publishes the 2024 Supervisory Board Report of Krka, d. d., Novo mesto.


The report will be published on the Company's website (www.krka.biz) from 10 April 2025 onwards, for a period of at least 10 years.
Annexes
File Description
2024 Supervisory Board Report.pdf
2024 Supervisory Board Report.pdf		 2024 Supervisory Board Report

KRKA, TOVARNA ZDRAVIL D.D.
(fullname of the issuer)
KRKA Farmaceutyczny (far)
(short name of the issuer) (sector according to clasification
of the WSE in Warsow)
8501 Nove Mesto
(post code) (city)
Smarjeska 6
(street) (number)
+386 7 331 21 11 +386 7 332 15 37
(phone number) (fax)
(e-mail) (web site)
nie dotyczy
(NIP) (REGON)

SIGNATURE OF PERSONS REPRESENTING THE COMPANY
Date Name Position / Function Signature
2025-04-10 Jože Colarič President of the Management Board and CEO
20250410_083532_1117161027_2024_Supervisory_Board_Report.pdf

Pobierz